Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　― Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers ―

Background: The prognosis of pulmonary arterial hypertension (PAH) has been improving since the introduction of epoprostenol (EPO). The 3-year survival of naïve idiopathic PAH (IPAH) and hereditary PAH (HPAH) was 96% in a recent prospective Japanese registry. This increase in survival in Japan may h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Midori, Takeuchi, Kaori, Kikuchi, Hanako, Goda, Ayumi, Inami, Takumi, Tamura, Yuichi, Kataoka, Masaharu, Fukuda, Keiichi, Satoh, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921359/
https://www.ncbi.nlm.nih.gov/pubmed/33693237
http://dx.doi.org/10.1253/circrep.CR-20-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921359/
https://www.ncbi.nlm.nih.gov/pubmed/33693237
http://dx.doi.org/10.1253/circrep.CR-20-0006

Ejemplares similares